Viral Excretion in Cervicovaginal Secretions of HIV-1-Infected Women Receiving Antiretroviral Therapy
β Scribed by M. Debiaggi; F. Zara; A. Spinillo; A. De Santolo; R. Maserati; R. Bruno; P. Sacchi; G. Achilli; A. Pistorio; E. Romero; G. Filice
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 82 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0934-9723
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Human immunodeficiency virus type 1 (HIV-1) infected patients treated with combination antiretroviral therapy frequently have the level of HIV-1 RNA detectable in plasma driven below the lower limit of detection of current assays, 50 copies ml(-1). Patients may continue to exhibit viral loads (VLs)
## Abstract ## Background Despite the correlation between the use of protease inhibitors (PI) and adverse metabolic glycemic events, no prospective study has examined these parameters in pregnant women who use these drugs. ## Methods A prospective study was conducted on 57 pregnant women to inve
## Abstract ## Purpose. The aim of our study was to evaluate whether perirenal fat thickness (PRFT), a parameter of central obesity, is related to carotid intimaβmedia thickness (IMT), an index of atherosclerosis in human immunodeficiency virus (HIV)β1βinfected patients. ## Methods. We enrolled
In order to evaluate the immunogenicity and the effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy (HAART), 29 children infected with HIV-1 vertically (19 primed with a previous influenza vaccinat